Reportlinker.com announced the release of "(2020-2025) Pharmaceutical Glass Packaging Market Growth, Trends and Forecasts". Glass packaging bottles are one of the main packaging materials in the pharmaceutical industry because they limit the alkalinity and hydrolysis resistance of glass containers. In 2019, the global pharmaceutical glass packaging bottle market is valued at US$151.55 billion and is expected to reach US$256.97 billion in 2025. The compound annual growth rate during this period is 9.17%.
The pharmaceutical and medical device industries are highly regulated and emphasize the safety and sustainability of manufacturing and packaging processes. To combat counterfeit drugs and medical devices, legislation has been enacted throughout the healthcare sector. For example, in October 2019, Corning announced the establishment of a joint pharmaceutical company, which was approved by the FDA. Corning Valor glass will serve as the main packaging bottle for pharmaceutical products on the market. This innovative glass packaging bottle solution is following the new trend of the market.
The growth of the pharmaceutical industry in emerging economies is driving the market. Glass packaging bottle manufacturers and suppliers are focusing on moving their bases to China, India and Brazil, as the pharmaceutical industry in these countries provides more and more opportunities, especially in the generic drug sector. For example, in April 2019, SCHOTT invested 50 million reais to produce pharmaceutical tubes in Rio de Janeiro as part of its global growth strategy.
In addition, India has 60,000 generic brands in 60 treatment categories and produces more than 500 different active pharmaceutical ingredients. The Ministry of Pharmaceuticals aims to make the country an end-to-end drug R&D center under its "Pharmaceutical Vision 2020".
With the increase in recyclability, the commodity value of glass is driving the market. Pharmaceutical packaging accounts for a small percentage of waste because most of it is used for glass as a material. In addition, the glass bottle is also 100% recyclable, which makes it an ideal bottle choice from an environmental point of view. In addition, colored glass, such as amber glass and red colored glass, can protect its contents from ultraviolet rays and certain wavelengths. Glass containers can be easily sterilized, making them ideal materials for pharmaceutical packaging.
Piramal Enterprise announced the use of environmentally friendly power supply and recycled glass to reduce our overall energy consumption and carbon emissions, thereby promoting a safer and greener corporate working environment. Recently, the company has also developed thin, lightweight glass bottles, further reducing the company's energy and raw material consumption. Similarly, Gerresheimer is also committed to sustainable trends throughout the department. The company has used post-consumer recycling (PCR) materials to produce glass for more than ten years in Belgium.
In addition, the spread of COVID-19 has had a negative impact on the market, initially due to supply chain disruptions caused by global production delays. However, the situation changed later. For example, FEVE (European Federation of Glass Containers and Machine Glass Manufacturers) called on the authorities to recognize the key role of glass bottle manufacturing and subcontracting, leading the continuous manufacturing of all factories and providing people with food, beverages and medicines.
However, in terms of logistics, manufacturers of bottles, vials and ampoules have difficulty supplying pharmaceutical companies. For example, AGIglaspac's pharmaceutical sector, which currently accounts for 30-32% of the Indian pharmaceutical packaging bottle industry, is facing production blockage, supply impact and inventory increase. So far, the company is partially using limited raw materials.